Cardiovascular Outcomes of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors Among Patients with Benign Prostatic Hyperplasia

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.